0001209191-11-031081.txt : 20110525
0001209191-11-031081.hdr.sgml : 20110525
20110525201410
ACCESSION NUMBER: 0001209191-11-031081
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110523
FILED AS OF DATE: 20110525
DATE AS OF CHANGE: 20110525
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KRUMEL CAROLINE J
CENTRAL INDEX KEY: 0001511233
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19756
FILM NUMBER: 11872347
MAIL ADDRESS:
STREET 1: C/O 932 SOUTHWOOD BOULEVARD
CITY: INCLINE VILLAGE
STATE: NV
ZIP: 89451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PDL BIOPHARMA, INC.
CENTRAL INDEX KEY: 0000882104
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943023969
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 932 SOUTHWOOD BLVD
CITY: INCLINE VILLAGE
STATE: NV
ZIP: 89451
BUSINESS PHONE: 775-832-8500
MAIL ADDRESS:
STREET 1: 932 SOUTHWOOD BLVD
CITY: INCLINE VILLAGE
STATE: NV
ZIP: 89451
FORMER COMPANY:
FORMER CONFORMED NAME: PROTEIN DESIGN LABS INC/DE
DATE OF NAME CHANGE: 19930328
4
1
doc4.xml
FORM 4 SUBMISSION
X0303
4
2011-05-23
0
0000882104
PDL BIOPHARMA, INC.
PDLI
0001511233
KRUMEL CAROLINE J
932 SOUTHWOOD BOULEVARD
INCLINE VILLAGE
NV
89451
0
1
0
0
Vice President of Finance
Common Stock
2011-05-23
4
A
0
4583
0.00
A
4583
D
The shares will vest on December 31, 2012, provided Ms. Krumel is continuously employed by the Company through such date. In the event Ms. Krumel is terminated by PDL without cause or resigns for good reason, the shares shall ratably accelerate and vest in proportion to the time lapsed during the vesting period. During the vesting period, Ms. Krumel has the right to vote the shares and will receive any dividends and other shareholder distributions paid by PDL. Such dividends and other distributions shall accumulate with interest and will vest and pay if and when the underlying shares vest.
/s/ Danny J Hart, Jr., Attorney-in-Fact for Caroline J. Krumel
2011-05-25